| Identification | Back Directory | [Name]
Acetamide, 2-amino-N-[[4-[[[3,5-dicyano-4-ethyl-6-(hexahydro-4-methyl-1H-1,4-diazepin-1-yl)-2-pyridinyl]thio]methyl]phenyl]methyl]- | [CAS]
2170136-86-2 | [Synonyms]
GSK3735967
Acetamide, 2-amino-N-[[4-[[[3,5-dicyano-4-ethyl-6-(hexahydro-4-methyl-1H-1,4-diazepin-1-yl)-2-pyridinyl]thio]methyl]phenyl]methyl]- | [Molecular Formula]
C25H31N7OS | [MOL File]
2170136-86-2.mol | [Molecular Weight]
477.62 |
| Chemical Properties | Back Directory | [Boiling point ]
739.8±60.0 °C(Predicted) | [density ]
1.28±0.1 g/cm3(Predicted) | [form ]
Solid | [pka]
14.48±0.46(Predicted) | [color ]
Off-white to yellow |
| Hazard Information | Back Directory | [Uses]
GSK3735967 is an selective, reversible, non-nucleoside inhibitor of DNMT1 with an IC50 value of 40 nM. GSK3735967 contains a planar dicyanopyridine core that can specifically embed DNMT1 bound hemimethylated CpG dinucleotides. GSK3735967 has three binding sites, one of which can bind to histone H4K20me3[1][2]. | [References]
[1] Horton JR, et al. Structural characterization of dicyanopyridine containing DNMT1-selective, non-nucleoside inhibitors. Structure. 2022 Jun 2;30(6):793-802.e5. DOI:10.1016/j.str.2022.03.009
[2] Horton J, et al. Structural Studies of DNMT1-DNA Complexes with a Reversible Series of Dicyanopyridine Containing Selective, Non-Nucleoside Inhibitors[J]. Foundations of Crystallography, 2022, 78: a246. |
|
|